RGENTA
Live / Registered — Registered (as of 14 Oct 2025)
What this means for you
Registered since 14 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98612558
- Registration number
- 7980641
- Mark type
- Stylized text
- Filed
- 21 Jun 2024
- Published for opposition
- 26 Aug 2025
- Registered
- 14 Oct 2025
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceutical preparations for the treatment of oncological, neurological, immunological, cardio-metabolic, and rare diseases and disorders in humans; providing scientific information in the field of research for treatments of oncological, neurological, immunological, cardio-metabolic, and rare diseases and disorders in humans
Owner
- Rgenta Therapeutics, Inc., Woburn, MA, US
- Rgenta Therapeutics, Inc., Woburn, MA, US
- Rgenta Therapeutics, Inc., Woburn, MA, US
Prosecution history
- 14 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 26 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Aug 2025 — PUBLISHED FOR OPPOSITION
- 20 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Jul 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Mar 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 10 Mar 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 15 Jan 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Jan 2025 — NON-FINAL ACTION E-MAILED
- 15 Jan 2025 — NON-FINAL ACTION WRITTEN
- 15 Jan 2025 — ASSIGNED TO EXAMINER